Sunbelt Securities »

Inhibrx Biosciences shares owned by Sunbelt Securities

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Sunbelt Securities from 13F filings

Historical chart of Sunbelt Securities investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Sunbelt Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Sunbelt Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $269 8 33.63

More positions owned by Sunbelt Securities

Exxon Mobil Corp Stock (XOM)
Nvidia Corporation Stock (NVDA)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Ishares Gold Trust Etf (IAU)
Broadcom Stock (AVGO)
Ishares S&p 500 Growth Etf Etf (IVW)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Invesco Qqq Trust Series I Etf (QQQ)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Ishares Core S&p 500 Etf Etf (IVV)
Amazon Stock (AMZN)
Spdr S&p 500 Etf Trust Etf (SPY)
Palantir Technologies Inc Cl A Stock (PLTR)
Innovator Defined Wealth Shield Etf Etf (BALT)

View all positions for Sunbelt Securities

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Woodline Partners
Millennium Management
Partner Fund Management
Caligan Partners
Geode Capital Management
State Street Corporation
Readystate Asset Management
Kennedy Capital Management

View all funds holding Inhibrx Biosciences